SM
CLVS

Sabby Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Sabby Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,065
Closed -$560K – 224
2017
Q2 		$661K Buy
+7,065
New +$432K 0.04% 122
2016
Q3 		– Sell
-59,836
Closed -$1.28M – 348
2016
Q2 		$821K Buy
59,836
+46,510
+349% +$680K 0.04% 174
2016
Q1 		$256K Sell
13,326
-7,597
-36% -$161K 0.01% 250
2015
Q4 		$732K Buy
+20,923
New +$1.35M 0.04% 210
2014
Q3 		– Sell
-20,000
Closed -$828K – 308
2014
Q2 		$828K Buy
+20,000
New +$1.03M 0.04% 164

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sabby Management's CLVS Position: Q3 2017 in Review

Sabby Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 7,065 shares — an estimated $560K sold.

Sabby Management first reported a position in CLVS in Q2 2014 and held it in 5 quarters. The position peaked at $828K in Q2 2014. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Sabby Management reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Sabby Management sold 7,065 Clovis Oncology, Inc. shares in Q3 2017, an estimated $560K.
  • Sabby Management first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 5 quarters.
  • Sabby Management's Clovis Oncology, Inc. position peaked at $828K in Q2 2014.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.